Nemolizumab for treating prurigo nodularis [ID6451]

Draft guidance

Draft guidance (online commenting)

Committee papers (PDF 4.3 MB)

Public committee slides (PDF 463 KB)

Equality impact assessment (downloadable version) (PDF 133 KB)

Final scope (PDF 115 KB)

Final stakeholder list (PDF 133 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 372 KB)